These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34922639)

  • 1. COVID-19 vaccine strategies must focus on severe disease and global equity.
    McIntyre PB; Aggarwal R; Jani I; Jawad J; Kochhar S; MacDonald N; Madhi SA; Mohsni E; Mulholland K; Neuzil KM; Nohynek H; Olayinka F; Pitisuttithum P; Pollard AJ; Cravioto A
    Lancet; 2022 Jan; 399(10322):406-410. PubMed ID: 34922639
    [No Abstract]   [Full Text] [Related]  

  • 2. Five priorities for universal COVID-19 vaccination.
    Abecassis A
    Lancet; 2021 Jul; 398(10297):285-286. PubMed ID: 34147157
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 vaccinations: The unknowns, challenges, and hopes.
    Mohamed K; Rzymski P; Islam MS; Makuku R; Mushtaq A; Khan A; Ivanovska M; Makka SA; Hashem F; Marquez L; Cseprekal O; Filgueiras IS; Fonseca DLM; Mickael E; Ling I; Arero AG; Cuschieri S; Minakova K; Rodríguez-Román E; Abarikwu SO; Faten AB; Grancini G; Cabral-Marques O; Rezaei N
    J Med Virol; 2022 Apr; 94(4):1336-1349. PubMed ID: 34845731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study.
    Wang W; Wu Q; Yang J; Dong K; Chen X; Bai X; Chen X; Chen Z; Viboud C; Ajelli M; Yu H
    BMJ; 2020 Dec; 371():m4704. PubMed ID: 33323388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.
    Cooper DM; Afghani B; Byington CL; Cunningham CK; Golub S; Lu KD; Radom-Aizik S; Ross LF; Singh J; Smoyer WE; Lucas CT; Tunney J; Zaldivar F; Ulloa ER
    Pediatr Res; 2021 Nov; 90(5):966-970. PubMed ID: 33627824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: vaccination problems.
    Brüssow H
    Environ Microbiol; 2021 Jun; 23(6):2878-2890. PubMed ID: 33928745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity.
    Han S; Cai J; Yang J; Zhang J; Wu Q; Zheng W; Shi H; Ajelli M; Zhou XH; Yu H
    Nat Commun; 2021 Aug; 12(1):4673. PubMed ID: 34344871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    Rid A; Lipsitch M; Miller FG
    JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations.
    Botton J; Semenzato L; Jabagi MJ; Baricault B; Weill A; Dray-Spira R; Zureik M
    JAMA Netw Open; 2022 Mar; 5(3):e220868. PubMed ID: 35234883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equitable global access to coronavirus disease 2019 vaccines.
    Schwartz JL
    BMJ; 2020 Dec; 371():m4735. PubMed ID: 33323384
    [No Abstract]   [Full Text] [Related]  

  • 11. The variants of SARS-CoV-2 and the challenges of vaccines.
    Han X; Ye Q
    J Med Virol; 2022 Apr; 94(4):1366-1372. PubMed ID: 34890492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines mix-and-match: The concept, the efficacy and the doubts.
    Rashedi R; Samieefar N; Masoumi N; Mohseni S; Rezaei N
    J Med Virol; 2022 Apr; 94(4):1294-1299. PubMed ID: 34796525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.
    Hsu CM; Weiner DE; Manley HJ; Aweh GN; Ladik V; Frament J; Miskulin D; Argyropoulos C; Abreo K; Chin A; Gladish R; Salman L; Johnson D; Lacson EK
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):403-413. PubMed ID: 35144972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic disorders, COVID-19 and vaccine-breakthrough infections.
    Stefan N
    Nat Rev Endocrinol; 2022 Feb; 18(2):75-76. PubMed ID: 34873287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.
    Malek AE; Cornejo PP; Daoud N; Alam M
    Immunotherapy; 2022 Feb; 14(2):91-94. PubMed ID: 34747190
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination and COVID-19 Dynamics in Dialysis Patients.
    El Karoui K; Hourmant M; Ayav C; Glowacki F; Couchoud C; Lapidus N;
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):395-402. PubMed ID: 35144970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
    Fang F; Clemens JD; Zhang ZF; Brewer TF
    PLoS One; 2024; 19(4):e0301830. PubMed ID: 38656933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.
    Massinga Loembé M; Nkengasong JN
    Immunity; 2021 Jul; 54(7):1353-1362. PubMed ID: 34260880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2-Dominant Period, Japan.
    Ogata T; Tanaka H; Kon A; Sakaibori N; Tanaka E
    Emerg Infect Dis; 2024 Jul; 30(7):1430-1433. PubMed ID: 38916601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. India's COVID-19 vaccination drive: key challenges and resolutions.
    Choudhary OP; Choudhary P; Singh I
    Lancet Infect Dis; 2021 Nov; 21(11):1483-1484. PubMed ID: 34529961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.